| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.23 | 0.0001 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |